Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3088096)

Published in Cardiol Res Pract on April 07, 2011

Authors

Halliday A Idikio1

Author Affiliations

1: Department of Laboratory Medicine and Pathology, University of Alberta, Room 5B4.11 WCM-HSC, 8440-112th Street, Edmonton, AB, Canada T6R 2B7.

Articles citing this

Autophagy: an affair of the heart. Heart Fail Rev (2013) 0.97

Articles cited by this

(truncated to the top 100)

Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18

Evidence for cardiomyocyte renewal in humans. Science (2009) 14.17

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation (1990) 9.74

Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res (2007) 8.44

Suppression of aging in mice by the hormone Klotho. Science (2005) 8.11

Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med (2007) 8.06

Recent progress in the biology and physiology of sirtuins. Nature (2009) 7.73

Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09

Understanding the odd science of aging. Cell (2005) 6.50

Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res (2004) 6.34

Augmented Wnt signaling in a mammalian model of accelerated aging. Science (2007) 5.62

Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest (2005) 5.53

DNA repair, genome stability, and aging. Cell (2005) 5.52

Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res (2007) 5.23

Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation (2003) 4.43

Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science (2008) 4.32

Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest (2009) 4.29

Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13

The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet (2006) 3.93

Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation (2005) 3.86

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation (2003) 3.62

AGEMAP: a gene expression database for aging in mice. PLoS Genet (2007) 3.22

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol (2009) 2.94

Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem (2005) 2.94

Tackling heart failure in the twenty-first century. Nature (2008) 2.93

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation (2009) 2.93

Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation (2003) 2.87

Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci (2006) 2.85

Two faces of p53: aging and tumor suppression. Nucleic Acids Res (2007) 2.78

Altered patterns of gene expression in response to myocardial infarction. Circ Res (2000) 2.76

Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71

Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res (2005) 2.63

Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science (2009) 2.60

Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell (2009) 2.58

Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation (2006) 2.56

Cardiac cell therapy--mixed results from mixed cells. N Engl J Med (2006) 2.52

MicroRNAs and cardiac pathology. Nat Rev Cardiol (2009) 2.50

The ageing immune system: is it ever too old to become young again? Nat Rev Immunol (2009) 2.48

The longest telomeres: a general signature of adult stem cell compartments. Genes Dev (2008) 2.38

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22

Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21

The Human Ageing Genomic Resources: online databases and tools for biogerontologists. Aging Cell (2008) 2.19

Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol (2009) 2.00

Melatonin signaling and cell protection function. FASEB J (2010) 1.99

Heart failure and the aging population: an increasing burden in the 21st century? Heart (2003) 1.96

Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92

Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res (2006) 1.92

Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci (2009) 1.90

Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol (2008) 1.90

The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev (2007) 1.88

NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res (2006) 1.88

Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res (2008) 1.80

Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res (2005) 1.76

The influence of genes on the aging process of mice: a statistical assessment of the genetics of aging. Genetics (2004) 1.72

Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest (2009) 1.69

The shock of aging: molecular chaperones and the heat shock response in longevity and aging--a mini-review. Gerontology (2009) 1.69

Stressin' Sestrins take an aging fight. EMBO Mol Med (2010) 1.65

Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc (2009) 1.62

Ageing and telomeres: a study into organ- and gender-specific telomere shortening. Nucleic Acids Res (2003) 1.59

A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J (2009) 1.56

Genes encoding longevity: from model organisms to humans. Aging Cell (2008) 1.53

Cardiovascular disease delay in centenarian offspring. J Gerontol A Biol Sci Med Sci (2004) 1.50

Calorie restriction and the exercise of chromatin. Genes Dev (2009) 1.44

Pursuing cardiac progenitors: regeneration redux. Cell (2005) 1.43

Human telomere structure and biology. Annu Rev Genomics Hum Genet (2008) 1.43

Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol (2008) 1.42

Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J (2005) 1.40

The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr (2001) 1.40

The Wnt signaling pathway: aging gracefully as a protectionist? Pharmacol Ther (2008) 1.38

Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation (2007) 1.31

Negative regulators of cardiac hypertrophy. Cardiovasc Res (2004) 1.29

Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol (2009) 1.29

Association of longer telomeres with better health in centenarians. J Gerontol A Biol Sci Med Sci (2008) 1.28

Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age. Am J Physiol Regul Integr Comp Physiol (2002) 1.22

Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging (2008) 1.17

Aging, telomeres, and atherosclerosis. Cardiovasc Res (2005) 1.17

Aging of signal transduction pathways, and pathology. Exp Cell Res (2008) 1.16

Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res (2003) 1.15

Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res (2006) 1.13

Aging mechanisms. Proc Natl Acad Sci U S A (2000) 1.08

The association of telomere length with paternal history of premature myocardial infarction in the European Atherosclerosis Research Study II. J Mol Med (Berl) (2008) 1.06

Aging effects on heart rate variation. J Gerontol (1991) 1.03

Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. Cardiovasc Res (2008) 0.99

Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J (2001) 0.99

Sestrins at the crossroad between stress and aging. Aging (Albany NY) (2010) 0.98

Left ventricular function and remodeling after myocardial infarction in aging rats. Am J Physiol (1997) 0.97

Blueberry-enriched diet protects rat heart from ischemic damage. PLoS One (2009) 0.96

Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc Res (2008) 0.94

Melatonin, immune function and aging. Immun Ageing (2005) 0.93

Energy metabolism, altered proteins, sirtuins and ageing: converging mechanisms? Biogerontology (2007) 0.93

Postinfarction left ventricular remodelling: where are the theories and trials leading us? Heart (2000) 0.91

Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network. PLoS One (2010) 0.89

Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J (2008) 0.87

Vitamins in aging, health, and longevity. Clin Interv Aging (2006) 0.84

Anti-ageing strategies: prevention or therapy? Showing ageing from within. EMBO Rep (2005) 0.83

Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol (2005) 0.82

Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin. FASEB J (2006) 0.81

Stem cell review series: regulating highly potent stem cells in aging: environmental influences on plasticity. Aging Cell (2008) 0.81